“We welcome the Obama administration’s announcement of a farsighted effort to treat millions more [people living with HIV] abroad, especially in sub-Saharan Africa,” a New York Times editorial writes. “The administration expects that the expanded treatments can be paid for with existing resources, by pushing for greater efficiencies and more financing from recipient nations. But if that effort stalls, the administration should re-evaluate quickly whether to ask Congress for money,” the editorial states.
In this post in the Hill’s “Congress Blog,” Kaitlin Christenson, the coalition director of the Global Health Technologies Coalition; Jim Connolly, president and CEO of Aeras; and Mel Spigelman, president and CEO of the TB Alliance, respond to a recently released G-FINDER report that shows “overall global investment in the research and development (R&D) of [new global health technologies] has declined for the first time since 2007, when the tracking of such funding began,” writing, “This decline is especially troubling given that there are more than 100 products in [the Product Development Partnerships' (PDPs)] pipelines.”
In order for Rwanda to reach its HIV prevention goals, the country “need[s] to reach two million men in two years to benefit from the protective effect of [voluntary medical male circumcision] in order to achieve this as part of a comprehensive, combination HIV prevention strategy,” Agnes Binagwahois, Rwanda’s minister of health, writes in a Washington Post opinion piece. However, “the only method widely approved for funding is the surgical method, which is expensive and impractical for countries lacking physicians and surgical infrastructure,” and it would take more than 12 years to reach the country’s goal, she says.
In this post in Huffington Post’s “Impact” blog, Orin Levine of the Department of International Health at Johns Hopkins Bloomberg School of Public Health and executive director of the International Vaccine Access Center (IVAC) recounts recent progress in expanding vaccine access to the world’s poor, writing, “From rolling out the first diarrhea vaccines in Africa, to doubling the number of low-income countries approved for vaccines against pneumonia, to announcing they will now assist countries [to] introduce vaccines for that prevent cervical cancer, the GAVI Alliance and its partners are tearing down the barriers to vaccine access that have historically divided rich from poor on our planet. To appreciate how far we’ve come you need to remember where we started.”
In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years “is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic.”
“[S]topping the AIDS pandemic requires sustained engagement from both donor and developing countries, political commitments that are backed by dollars. … Yet many donor countries have chosen precisely this moment to abandon their promises,” they write. They discuss the cancellation of Round 11 grants by the Global Fund to Fight AIDS, Tuberculosis and Malaria, and ask the Canadian government to deliver on its HIV/AIDS funding pledges. Elliott and Stein conclude, “We can turn the tide on the spread of HIV — victory has never been closer. But we need to make sure that those with the power and the money use it toward achieving the goal of an end to AIDS” (12/7).
Women “bea[r] the brunt” of weather-related disasters, but they also are “the key to stopping global warming, and to helping communities around the world adapt to the damage that has already been done,” Mary Pittman, president and CEO of the Public Health Institute (PHI), and Kavita Ramdas, executive director of…
In this Foreign Affairs opinion piece, Mead Over, a senior fellow at the Center for Global Development, says the goal of an “AIDS-free generation” is attainable, “[b]ut not if treatment continues to take precedence over prevention.” He continues, “It is unfortunate that so many have focused on treatment alone because there is a way to end the global scourge of HIV/AIDS: by conditioning the rate of expansion of treatment programs on the reduction of new infections. This much-needed shift would lead to what I call an AIDS transition — the day on which the rate of new infections falls below the rate of AIDS-related deaths so that the number of people living with HIV/AIDS decreases year-on-year.”
After “President Obama threw the full weight of the U.S. government behind a vision” to end the AIDS epidemic in a World AIDS Day speech, “[n]ow the question is: How will we achieve this goal? What are the priority actions to take today, tomorrow, and years from now?” Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention, writes in the Huffington Post’s “Impact” blog. “First and foremost, the resource commitments need to match the strength of the scientific data,” he says, adding, “It is precisely at this moment, when the potential dividends are greatest, that the world’s modest AIDS investments should be sustained.”
In this post in USAID’s “IMPACTblog,” Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d’Ivoire with her colleagues in June. “I have seen the importance…
In this Knowledge for Health (K4Health) blog post, Elsie Mwaniki, a communication specialist at K4Health, reflects on the integration of family planning and HIV services, writing, “Many HIV-positive women have an unmet need for family planning (FP) services,” so providing these services together (FP/HIV integration) “makes sense.” She recaps a panel discussion…